This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Answer by the authors to the letter of Dr. Wang and colleagues, concerning our case report entitled "Idarucizumab for dabigatran overdose". (2nd January 2017)
Record Type:
Journal Article
Title:
Answer by the authors to the letter of Dr. Wang and colleagues, concerning our case report entitled "Idarucizumab for dabigatran overdose". (2nd January 2017)
Main Title:
Answer by the authors to the letter of Dr. Wang and colleagues, concerning our case report entitled "Idarucizumab for dabigatran overdose"